Open AccessA Review on the Relationship between Matrix Metalloproteinases (Mmps) and their Natural Inhibitors (Tissue Inhibitors Of Matrix Metalloproteinases [Timps]) and the Success of an Autologous Arteriovenous Fistula (Avf)
Author(s) -
Mohd Norhisham Azmi Abdul Rahman,
Ahmad Faidzal Othman
Publication year - 2021
Publication title -
international medical journal malaysia/iium medical journal malaysia
Language(s) - English
Resource type - Journals
eISSN - 2735-2285
pISSN - 1823-4631
DOI - 10.31436/imjm.v20i4.1823
Subject(s) - matrix metalloproteinase , medicine , intimal hyperplasia , arteriovenous fistula , myofibroblast , extracellular matrix , vascular smooth muscle , hyperplasia , matrix (chemical analysis) , fistula , pathology , smooth muscle , surgery , microbiology and biotechnology , fibrosis , biology , materials science , composite material
Since its introduction by Brescia and Cimino in 1966, arteriovenous fistula has been regarded as the best vascular access for haemodialysis purpose. However, it’s not without any drawbacks which has cost over USD1 billion in the United States alone to rectify them. Intimal hyperplasia has been shown to be a major contributory factor to this development. Intimal hyperplasia is a complex molecular process resulting in unwarranted accumulation of contractile smooth muscle cells, myofibroblasts, fibroblasts, and macrophages. There is an increasing amount of evidence suggesting that matrix metalloproteinases (MMPs) and its natural inhibitors (tissue inhibitors of matrix metalloproteinases ([TIMPs]) play a pivotal role in the development of intimal hyperplasia. Our purpose of writing this review article is to examine these evidences and to suggest of what future research questions need to be answered to further strengthen and clarify this relationship.